Talc Case: Johnson & Johnson to Pay $5.5 Billion to Settle Lawsuits

Johnson & Johnson will pay $5.5 billion to settle approximately 76,000 lawsuits in the talc cancer case. The settlement includes a $3 billion payment next year and the remainder from 2028. The company denied the allegations but stopped selling the product in the US in 2020. The settlement requires approval from 95% of claimants.

American pharmaceutical manufacturer Johnson & Johnson will pay $5.5 billion to settle lawsuits filed against it in the talc cancer case. Under the settlement terms, the company will pay $3 billion next year and the remaining amount starting in 2028. The settlement covers approximately 76,000 claims, representing nearly all remaining lawsuits against it. The company consistently denied the allegations but stopped selling the product in the US in 2020 and worldwide two years later. A similar lawsuit is pending against the company in the UK. Over the years, the company has achieved mixed results in lawsuits, losing some. Legal proceedings were halted for three years from 2022 due to the company's attempts to file for bankruptcy through shell companies, but these moves were blocked by the court. The settlement requires approval from 95% of claimants to become final.